Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis
- PMID: 22672987
- DOI: 10.1097/IGC.0b013e318256e5e4
Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis
Abstract
Objective: The objectives of this study were to assess the accuracy of 6 common cervical screening strategies, including visual inspection with acetic acid, with a magnifying device, or with Lugol iodine (VILI), human papillomavirus testing with Hybrid Capture 2 assay, conventional Papanicolaou smear, and thin liquid-based cytology (LBC), and then to compare data obtained by the aforementioned 6 strategies.
Methods: PubMed, EMBASE, and The Cochrane Library were systematically searched for all original relevant studies about early detection of cervical cancer. A meta-analysis was performed to evaluate the accuracy of the 6 screening strategies covering sensitivity, specificity, diagnostic odds ratio, and the area under the receiver operating characteristic curve.
Results: Fifteen articles containing 22 cross-sectional studies were finally identified. The combined estimates of sensitivity for visual inspection with acetic acid, magnified visual inspection with acetic acid, VILI, Hybrid Capture 2 assay, conventional Papanicolaou smear, and LBC were 77%, 64%, 91%, 74%, 59%, and 88%, respectively; the combined values of specificity of these screening strategies were 87%, 86%, 85%, 92%, 94%, and 88%, respectively; the diagnostic odds ratio were 22.43, 10.30, 57.44, 33.26, 22.49, and 51.56, respectively; and the area under the receiver operating characteristic curve were 0.8918, 0.7737, 0.9365, 0.9486, 0.9079, and 0.9418, respectively.
Conclusions: This meta-analysis suggests that LBC appeared to be promising in primary cervical cancer screening in resourced regions, and VILI might be a good choice to identify/exclude cervical cancerous and precancerous lesions in resource-constrained regions.
Similar articles
-
Diagnostic accuracy for alternative cervical cancer screening strategies: A systematic review and meta-analysis.Health Care Women Int. 2024;45(3):323-362. doi: 10.1080/07399332.2021.1998059. Epub 2022 Jan 27. Health Care Women Int. 2024. PMID: 35084291 Review.
-
Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.BMJ. 2015 Jul 3;351:h3084. doi: 10.1136/bmj.h3084. BMJ. 2015. PMID: 26142020 Free PMC article. Review.
-
Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.Int J Cancer. 2008 Jul 1;123(1):153-60. doi: 10.1002/ijc.23489. Int J Cancer. 2008. PMID: 18404671
-
Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?Gynecol Obstet Invest. 2015;80(3):153-63. doi: 10.1159/000371760. Epub 2015 Apr 1. Gynecol Obstet Invest. 2015. PMID: 25832290
-
[A study of cervical cancer screening algorithms].Zhonghua Zhong Liu Za Zhi. 2010 Jun;32(6):420-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20819481 Chinese.
Cited by
-
Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment.Med Oncol. 2023 Nov 6;40(12):347. doi: 10.1007/s12032-023-02195-3. Med Oncol. 2023. PMID: 37930458 Review.
-
A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling.Rev Bras Ginecol Obstet. 2023 May;45(5):235-241. doi: 10.1055/s-0043-1770134. Epub 2023 Jun 20. Rev Bras Ginecol Obstet. 2023. PMID: 37339642 Free PMC article.
-
Performance of screening tools for cervical neoplasia among women in low- and middle-income countries: A systematic review and meta-analysis.PLOS Glob Public Health. 2023 Feb 23;3(2):e0001598. doi: 10.1371/journal.pgph.0001598. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 36963095 Free PMC article.
-
Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.JAMA. 2020 Oct 20;324(15):1532-1542. doi: 10.1001/jama.2020.16244. JAMA. 2020. PMID: 33079153 Free PMC article.
-
Identification of Circulating MicroRNAs as a Promising Diagnostic Biomarker for Cervical Intraepithelial Neoplasia and Early Cancer: A Meta-Analysis.Biomed Res Int. 2020 Mar 23;2020:4947381. doi: 10.1155/2020/4947381. eCollection 2020. Biomed Res Int. 2020. PMID: 32280688 Free PMC article.
